Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold 1,064 shares of common stock to cover tax withholding obligations related to vesting RSUs.
Summary
- On August 16, 2024, John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold 1,064 shares of common stock.
- The sale was executed at a price of $18.504 per share.
- The transaction was intended to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Militello directly owns 51,451 shares of Rocket Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and does not contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation for executives. It is a normal part of doing business and is not necessarily indicative of the company's performance.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date of the transaction: sale of 1,064 shares of common stock. |
| 08/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.